SynthesisFrontiers in pharmacology2025

Toxicity profiles of ROS1 tyrosine kinase inhibitors in advanced non-small cell lung cancer: a systematic review and proportional meta-analysis.

Bo-Xuan Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.